
Sign up to save your podcasts
Or


This week, Kate, Henry and Mark discuss how much statins lower mortality, the cost-effectiveness of the new crop of Alzheimer's drugs, and whether surgery is helpful for a range of orthopedic conditions.
By Mark Ebell4.7
9292 ratings
This week, Kate, Henry and Mark discuss how much statins lower mortality, the cost-effectiveness of the new crop of Alzheimer's drugs, and whether surgery is helpful for a range of orthopedic conditions.

138 Listeners

702 Listeners

498 Listeners

288 Listeners

286 Listeners

262 Listeners

3,339 Listeners

1,154 Listeners

192 Listeners

88 Listeners

513 Listeners

369 Listeners

249 Listeners

372 Listeners

315 Listeners